BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 27904655)

  • 1. Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5'-monophosphate response element modulator alpha in systemic lupus erythematosus.
    Zhang Q; Ding S; Zhang H; Long H; Wu H; Zhao M; Chan V; Lau CS; Lu Q
    Clin Epigenetics; 2016; 8():126. PubMed ID: 27904655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4
    Luo S; Zhang H; Xie Y; Huang J; Luo D; Zhang Q
    Clin Epigenetics; 2022 Dec; 14(1):181. PubMed ID: 36536372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of aberrant H3K27me3 modification in promoter regions on cAMP response element modulator α expression in CD4
    Zhang Q; Ding S; Zhang HL
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Dec; 37(12):1597-1602. PubMed ID: 29292251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP-responsive element modulator (CREM)α protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus.
    Rauen T; Hedrich CM; Juang YT; Tenbrock K; Tsokos GC
    J Biol Chem; 2011 Dec; 286(50):43437-46. PubMed ID: 22025620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.
    Hedrich CM; Crispin JC; Rauen T; Ioannidis C; Apostolidis SA; Lo MS; Kyttaris VC; Tsokos GC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16606-11. PubMed ID: 23019580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREMα suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells.
    Ghosh D; Kis-Toth K; Juang YT; Tsokos GC
    Arthritis Rheum; 2012 Mar; 64(3):799-807. PubMed ID: 21953500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cAMP-responsive element modulator α (CREMα) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE).
    Hedrich CM; Rauen T; Kis-Toth K; Kyttaris VC; Tsokos GC
    J Biol Chem; 2012 Feb; 287(7):4715-25. PubMed ID: 22184122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
    Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
    J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus.
    Hedrich CM; Rauen T; Tsokos GC
    J Biol Chem; 2011 Dec; 286(50):43429-36. PubMed ID: 21976679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients.
    Dai Y; Zhang L; Hu C; Zhang Y
    Clin Exp Rheumatol; 2010; 28(2):158-68. PubMed ID: 20483040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.
    Zhao H; Wang L; Luo H; Li QZ; Zuo X
    Rheumatology (Oxford); 2017 May; 56(5):835-843. PubMed ID: 28158872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).
    Rauen T; Grammatikos AP; Hedrich CM; Floege J; Tenbrock K; Ohl K; Kyttaris VC; Tsokos GC
    J Biol Chem; 2012 Dec; 287(51):42525-32. PubMed ID: 23124208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.
    Liu Y; Liao J; Zhao M; Wu H; Yung S; Chan TM; Yoshimura A; Lu Q
    Eur J Immunol; 2015 Sep; 45(9):2683-93. PubMed ID: 26079624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus.
    Hofmann SR; Mäbert K; Kapplusch F; Russ S; Northey S; Beresford MW; Tsokos GC; Hedrich CM
    J Immunol; 2019 Dec; 203(11):2807-2816. PubMed ID: 31653682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.
    Hedrich CM; Crispín JC; Rauen T; Ioannidis C; Koga T; Rodriguez Rodriguez N; Apostolidis SA; Kyttaris VC; Tsokos GC
    J Biol Chem; 2014 Jan; 289(4):2361-70. PubMed ID: 24297179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
    Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
    J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase JMJD3 regulates CD11a expression through changes in histone H3K27 tri-methylation levels in CD4+ T cells of patients with systemic lupus erythematosus.
    Yin H; Wu H; Zhao M; Zhang Q; Long H; Fu S; Lu Q
    Oncotarget; 2017 Jul; 8(30):48938-48947. PubMed ID: 28430662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.
    Zhao M; Wu X; Zhang Q; Luo S; Liang G; Su Y; Tan Y; Lu Q
    Arthritis Res Ther; 2010; 12(6):R227. PubMed ID: 21192791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal histone modification patterns in lupus CD4+ T cells.
    Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
    J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant H3K4me3 modification of immune response genes in CD4
    Feng D; Zhao H; Wang Q; Wu J; Ouyang L; Jia S; Lu Q; Zhao M
    Int Immunopharmacol; 2024 Mar; 130():111748. PubMed ID: 38432146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.